The enhanced AUG3 translon expression observed in cluster 5 (samples from breast, ovary and prostate cancer cell lines) is consistent with previously observed elevated SRD5A1 activity in sex hormone related cancers (Lewis, Wiebe, and Heathcote 2004; Sinreih et al. 2015; Tanaka et al. 2015). This evidence concerns the gene SRD5A1 and prostate carcinoma.